Mainz Biomed NV
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Mainz Biomed's stock with a target price of $4, indicating strong growth potential.
Financial Health
Mainz Biomed is generating modest revenue and cash flow, but its profitability potential is still developing.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring MYNZ
German Stocks Soaring
Discover a carefully selected collection of German companies that have been dramatically outperforming their western counterparts. Our team of professional analysts has identified these standout stocks as Germany's economy shows promising signs of growth in 2025.
Published: May 15, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pipeline‑driven upside
Clinical milestones and regulatory updates can be catalysts for share moves, though outcomes are uncertain and can be volatile.
Market and adoption
Commercial adoption in diagnostics markets could support growth, but competition and reimbursement barriers mean success is not guaranteed.
Balance sheet watch
With a very small market cap, cash runway and funding plans are key; investors should expect possible dilution if capital is required.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
